增强现实双重任务干预改善了帕金森病患者的姿势稳定性
Anson B Rosenfeldt1, Matthew C Streicher2, Ryan D Kaya2
1Cleveland Clinic, Lerner Research Institute, Department of Biomedical Engineering, 9500 Euclid Ave, Cleveland, OH 44195, USA.
Gait & posture
|November 21, 2024
概括
使用传统方法或增强现实 (DART) 的双任务训练 (DTT) 改善了帕金森病 (PD) 患者的姿势稳定性和运动能力. 这两种干预措施都显示出类似的有效性,突出显示DART是PD管理的可行的数字治疗方法.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 数字治疗学数字治疗学
背景情况:
- 之前的研究证实了双重任务训练 (DTT) 对帕金森病 (PD) 步态的有效性.
- 姿势稳定性结果在主要的DART试验手稿中没有详细说明.
- 本研究通过分析姿势稳定性数据来弥补这一差距.
研究的目的:
- 为了比较传统的DTT和增强现实DTT (DART) 在姿势稳定性,功能移动性和转向PD方面.
- 测试两个DTT方法都能产生类似的改进的假设.
- 评估这些干预措施的长期影响.
主要方法:
- 47名患有PD的患者被随机分为传统DTT或DART组.
- 干预持续了8周,有16次会议.
- 姿势稳定性和定时启动和启动 (TUG) 测试在基线,治疗结束和治疗后8周进行.
主要成果:
- 两组在治疗结束时,最大外出区域和双重任务TUG时间均显著改善.
- 在单任务和双任务条件下,转参数 (持续时间,速度) 在两组中都得到改善.
- 干预结束8周后,转时间和平均转速度的改善持续了8周.
结论:
- 包括DART在内的认知运动训练有效地治疗PD患者的姿势不稳定.
- 在改善步态和稳定性方面,DART干预的效果与传统的DTT相提并论.
- DART是一种有前途的数字治疗方法,用于管理PD相关的步行和姿势缺陷.
更多相关视频
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.2K
13:44Haptic/Graphic Rehabilitation: Integrating a Robot into a Virtual Environment Library and Applying it to Stroke Therapy
Published on: August 8, 2011
13.8K
相关概念视频
01:24Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
01:15Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482